ArticleCancer chemotherapy and pharmacology2016

Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors.

Shivaani Kummar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.